HIT: Heparin Induced Thrombocytopenia

Heparin Induced Thrombocytopenia (HIT) is explored, emphasizing its antibody-mediated nature and the importance of recognizing platelet count drops in patients receiving heparin. HIT should be suspected when a patient's platelet count drops below 100,000 or decreases by 50% from their baseline. Diagnosis involves laboratory tests like platelet aggregation assays and ELISA, though these have limitations in sensitivity and specificity. Management requires stopping all heparins and avoiding warfarin, instead opting for antithrombotic agents like Agatraban or Lipirudin, while considering their respective risks, especially in patients with renal or liver issues. Even without thrombosis evidence, HIT-positive patients face high thrombosis risks, necessitating careful screening and potential prophylactic anticoagulation.

Outlines

Sign in to continue reading, translating and more.

Continue

ICU Rounds

Introduction to Heparin Induced Thrombocytopenia: Definition, Diagnosis, and Pathophysiology

Understanding Heparin Induced Thrombocytopenia: Antibody Formation, Frequency, and Suspicion Criteria

Differentiating HIT from Other Causes of Thrombocytopenia in the ICU

Diagnosing Heparin Induced Thrombocytopenia: Platelet Aggregation Assay and ELISA Test

Treatment Strategies for HIT: Antithrombotic Agents and Avoiding Warfarin

Thrombosis Risk in HIT Patients and Considerations for Antithrombotic Therapy

Summary of HIT Diagnosis, Treatment, and Thrombosis Risk Management

HIT: Heparin Induced Thrombocytopenia

ICU Rounds

00:00Introduction to Heparin Induced Thrombocytopenia: Definition, Diagnosis, and Pathophysiology

Introduction to Heparin Induced Thrombocytopenia: Definition, Diagnosis, and Pathophysiology

01:27Understanding Heparin Induced Thrombocytopenia: Antibody Formation, Frequency, and Suspicion Criteria

Understanding Heparin Induced Thrombocytopenia: Antibody Formation, Frequency, and Suspicion Criteria

04:49Differentiating HIT from Other Causes of Thrombocytopenia in the ICU

Differentiating HIT from Other Causes of Thrombocytopenia in the ICU

07:15Diagnosing Heparin Induced Thrombocytopenia: Platelet Aggregation Assay and ELISA Test

Diagnosing Heparin Induced Thrombocytopenia: Platelet Aggregation Assay and ELISA Test

09:15Treatment Strategies for HIT: Antithrombotic Agents and Avoiding Warfarin

Treatment Strategies for HIT: Antithrombotic Agents and Avoiding Warfarin

13:16Thrombosis Risk in HIT Patients and Considerations for Antithrombotic Therapy

Thrombosis Risk in HIT Patients and Considerations for Antithrombotic Therapy

16:33Summary of HIT Diagnosis, Treatment, and Thrombosis Risk Management

Summary of HIT Diagnosis, Treatment, and Thrombosis Risk Management